175
Views
1
CrossRef citations to date
0
Altmetric
Theme: Arrhythmias & Cardiac Pacing Review

Lifestyle and atrial fibrillation

Pages 895-902 | Published online: 10 Jan 2014

References

  • Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ. Cardiovasc. Qual. Outcomes4, 313–320 (2011).
  • Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA295, 1549–1555 (2006).
  • Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA288, 2569–2578 (2002).
  • Parikh P, McDaniel MC, Ashen MD et al. Diets and cardiovascular disease: an evidence-based assessment. J. Am. Coll. Cardiol.45, 1379–1387 (2005).
  • Mattioli AV. Effects of caffeine and coffee consumption on cardiovascular disease and risk factors. Future Cardiol.3, 203–212 (2007).
  • Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol consumption and cardiovascular mortality among US adults, 1987 to 2002. J. Am. Coll. Cardiol.55, 1328–1335 (2010).
  • Wang C, Harris WS, Chung M et al. n23 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr.84, 5–17 (2006).
  • Muntner P, He J, Cutler JA et al. Trends in blood pressure among children and adolescents. JAMA291, 2107–2113 (2004).
  • Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA288, 1723–1727 (2002).
  • Jeor ST, Howard BV, Prewitt TE et al.; for the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation104, 1869–1874 (2001).
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation106, 3143–3421 (2002).
  • Zarraga IGE, Schwarz ER. Impact of dietary patterns and interventions on cardiovascular health. Circulation114, 961–973 (2006).
  • Merkin MS, Shefer A, Berry EM et al. Fat-free diet and myocardial excitability, refractoriness and ventricular fibrillation. Arch. Int. Physiol. Biochim.95, 243–254 (1987).
  • Yusuf K, Jirapradittha J, Amin HJ, Yu W, Hasan SU. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency. Neonatology98(3), 260–264 (2010).
  • Wang TJ, Parise H, Levy D et al. Obesity and the risk of new-onset atrial fibrillation. JAMA292, 2471–2477 (2004).
  • Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am. J. Med.118, 489–495 (2005).
  • Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation mechanisms and implications. Circ. Arrhythmia Electrophysiol.1, 62–73 (2008).
  • De Las Fuentes L, Waggoner AD, Mohammed BS et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J. Am. Coll. Cardiol.54, 2376–2381 (2009).
  • Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am. J. Med. Sci.321, 225–236 (2001).
  • Guglin M, Maradia K, Chen R, Curtis AB. Relation of obesity to recurrence rate and burden of atrial fibrillation. Am. J. Cardiol.107, 579–582 (2011).
  • Shimazu T, Kuriyama S, Hozawa A et al. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int. J. Epidemiol.36, 610–611 (2007).
  • Cai H, Shu XO, Gao YT, Li H, Yang G, Zheng W. A prospective study of dietary patterns and mortality in Chinese women. Epidemiology18, 393–401 (2007).
  • Sacks FM, Svetkey LP, Vollmer WM et al.; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med.344, 3–10 (2001).
  • Sofi F, Cesari F, Abbate R et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ337, a1344 (2008).
  • Mitrou PN, Kipnis V, Thiebaut AC et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP diet and health study. Arch. Intern. Med.167, 2461–2468 (2007).
  • Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med.348, 2599–2608 (2003).
  • Shai I, Schwarzfuchs D, Henkin Y et al.; for the Dietary Intervention Randomized Controlled Trial (DIRECT) group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med.359, 229–241 (2008).
  • Sata N, Hamada N, Horinouchi T et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J.45, 441–445 (2004).
  • Frustaci A, Chimenti C, Bellocci F et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation96, 1180–1184 (1997).
  • Fung TT, McCullough ML, Newby PK et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr.82, 163–173 (2005).
  • Dai J, Miller AH, Bremner JD et al. Adherence to the Mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study. Circulation117, 169–175 (2008).
  • Pitsavos C, Panagiotakos DB, Tzima N et al. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. Am. J. Clin. Nutr.82, 694–699 (2005).
  • Mantzoros CS, Williams CJ, Manson JE et al. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am. J. Clin. Nutr.84, 328–335 (2006).
  • Barseghian A, Gawande D, Bajaj M. Adiponectin and vulnerable atherosclerotic plaques. J. Am. Coll. Cardiol.57, 761–770 (2011).
  • Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventós RM et al. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)–Spain cohort. Br. J. Nutr.100, 188–196 (2008).
  • Dedoussis GV, Kanoni S, Mariani E et al. Mediterranean diet and plasma concentration of inflammatory markers in old and very old subjects in the ZINCAGE population study. Clin. Chem. Lab. Med.46, 990–996 (2008).
  • Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr.16, 33–50 (1996).
  • Svilaas A, Sakhi AK, Andersen LF et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J. Nutr.134, 562–567 (2004).
  • Mattioli AV, Miloro C, Pennella S et al. Adherence to mediterranean diet and intake of antioxidants influence spontaneous conversion of atrial fibrillation. Nutr. Metab. Cardiovasc. Dis. (2011) (In press).
  • Opie LH, Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart J.28, 1683–1693 (2007).
  • Dai J, Lampert R, Wilson PW et al. Mediterranean dietary pattern is associated with improved cardiac autonomic function among middle-aged men. A twin study. Circ. Cardiovasc. Qual. Outcomes3(4), 366–373 (2010).
  • GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction results of the GISSI-Prevenzione trial. Lancet354, 447–455 (1999).
  • Yokoyama M, Origasa H, Matsuzaki M et al. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet369, 1090–1098 (2007).
  • Brouwer IA, Zock PL, Camm AJ et al. SOFA study group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter-defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA295, 2613–2619 (2006).
  • Zotos PC, Haboubi NA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J. Clin. Nutr.57, 193–200 (2003).
  • Raitt MH, Connor WE, Morris C et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA293, 2884–2891 (2005).
  • Nodari S, Metra M, Milesi G et al. The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc. Drugs Ther.23, 5–15 (2009).
  • Valli G, Giardina EG. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J. Am. Coll. Cardiol.39, 1083–1095 (2002).
  • Vogel JH, Bolling SF, Costello RB et al. Integrating complementary medicine into cardiovascular medicine: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J. Am. Coll. Cardiol.46, 184 –221 (2005).
  • Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol.55, 515–525 (2010).
  • Cohen RJ, Ek K, Pan CX. Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation. J. Gerontol. A Biol. Sci. Med. Sci.57, M223–M227 (2002)
  • Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA271, 840–844 (1994).
  • Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am. J. Clin. Nutr.81, 578–582 (2005).
  • Mattioli AV, Farinetti A, Miloro C et al. Influence of coffee and caffeine consumption on atrial fibrillation in hypertensive patients. Nutr. Metab. Cardiovasc. Dis.21, 412–417 (2011).
  • Mattioli AV. Coffee and caffeine effects on hypertension. Curr. Hypertens. Rev.3(4), 250–254 (2007).
  • Sondermeijer HP, van Marle AGJ, Kamen P, Krum H. 2002 acute effects of caffeine on heart rate variability. Am. J. Cardiol.90, 906–990 (2002).
  • Rauh R, Burkert M, Siepmann M, Mueck-Weymann M. Acute effects of caffeine on heart rate variability in habitual caffeine consumers. Clin. Physiol. Funct. Inaging26, 163–166 (2006).
  • Yeragani VK, Krishnan S, Engels HJ, Gretebeck R. Effects of caffeine on linear and nonlinear measures of heart rate variability before and after exercise. Depress. Anxiety21, 130–134 (2005).
  • Bonnett M, Tancer M, Uhde T, Yeragani VK. Effects of caffeine on heart rate and QT variability during sleep. Depress. Anxiety22, 150–155 (2005).
  • Conen D, Chiuve SE, Everett BM et al. Caffeine consumption and incident atrial fibrillation in women. Am. J. Clin. Nutr.92, 509–514 (2010).
  • Newcombe PF, Renton KW, Rautaharju PM et al. High-dose caffeine and cardiac rate and rhythm in normal subjects. Chest94, 90–94 (1988).
  • Hansson A, Madsen-Hardig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovasc. Disord.4, 13 (2004).
  • Mattioli AV, Bonatti S, Zennaro M et al. Effect of coffee consumption, lifestyle and acute life stress in the development of acute lone atrial fibrillation. J. Cardiovasc. Med.9, 794–798 (2008).
  • Lin CI, Vassalle M. Role of calcium in the inotropic effects of caffeine in cardiac Purkinje fibers. Int. J. Cardiol.3, 421–434 (1983).
  • Strubelt O, Diederich KW. Experimental treatment of the acute cardiovascular toxicity of caffeine. J. Toxicol. Clin. Toxicol.37, 29–33 (1999).
  • Shen J, Johnson VM, Sullivan LM et al. Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am. J. Clin. Nutr.93, 261–266 (2011).
  • Mattioli AV, Bonatti S, Zennaro M, Mattioli G. The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. Europace7(3), 211–220 (2005).
  • Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J. Intern. Med.250, 382–389 (2001).
  • Zhang Y, Post WS, Dalal D et al. Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey. PLoS One28, e17584 (2011).
  • Fankushen D, Raskin D, Dimich A, Wallach S. The significance of hypomagnesemia in alcoholic patients. Am. J. Med.37, 802–812 (1964).
  • Lim P, Jacob E. Magnesium status of alcoholic patients. Metabolism21, 1045–1051 (1972).
  • Schenk EA, Cohen J. The heart in chronic alcoholism. Clinical and pathologic findings. Pathol. Microbiol.35, 96–104 (1970).
  • Tsai CS, Loh SH et al. Effects of alcohol on intracellular pH regulators and electromechanical parameters in human myocardium. Alcohol Clin. Exp. Res.29, 1787–1795 (2005).
  • Thun MJ, Peto R, Lopez AD et al. Alcohol consumption and mortality among U.S. adults. N. Engl. J. Med.337, 1705–1714 (1997).
  • Ettinger PO, Wu CF, De La Cruz C Jr et al. Arrhythmias and the ‘holiday heart’: alcohol-associated cardiac rhythm disorders. Am. Heart J.95, 555–562 (1978).
  • Wannamethee G, Shaper AG. Alcohol and sudden cardiac death. Br. Heart J.68, 443–448 (1992).
  • Mukamal KJ, Psaty BM, Rautaharju PM et al. Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health Study. Am. Heart J.153, 260–266 (2007).
  • Djousse L, Levy D, Benjamin EJ et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am. J. Cardiol.93, 710–713 (2004).
  • Conen D, Tedrow UB, Cook NR et al. Alcohol consumption and risk of incident atrial fibrillation in women. JAMA300, 2489 (2008).
  • Balbao CE, de Paola AA, Fenelon G. Effects of alcohol on atrial fibrillation: myths and truths. Ther. Adv. Cardiovasc Dis.3, 53–63 (2009).
  • Lazarevic AM, Nakatani S, Neskovic AN et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J. Am. Coll. Cardiol.35, 1599–1606 (2000).
  • Awtry EH, Philippides GJ. Alcoholic and cocaine-associated cardiomyopathies. Prog. Cardiovasc. Dis.52, 289–299 (2010).
  • Kodama S, Saito K, Tanaka S et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J. Am. Coll. Cardiol.57, 427–436 (2011).
  • O’Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health. The razor–sharp double-edged sword. J. Am. Coll. Cardiol.50, 1009–1014 (2007).
  • Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J. Am. Coll. Cardiol.55, 1328–1335 (2010).
  • Di Castelnuovo A, Rotondo S, Iacoviello L et al. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation105, 2836–2844 (2002).
  • Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ312, 731–736 (1996).
  • Di Castelnuovo A, Costanzo S, Bagnardi V et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch. Intern. Med.166, 2437–2445 (2006).
  • White IR, Altmann DR, Nanchahal K. Alcohol consumption and mortality: modelling risks for men and women at different ages. BMJ325, 191 (2002).
  • Costanzo S, Di Castelnuovo A, Donati MB et al. Alcohol consumption and mortality in patients with cardiovascular sisease. A meta-analysis. J. Am. Coll. Cardiol.55, 1333–1347 (2010).
  • Estruch R, Sacanella E, Badia E et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis175, 117–123 (2004).
  • Gorelik S, Ligumsky M, Kohen R, Kanner J. The stomach as a ‘bioreactor’: when red meat meets red wine. J. Agric. Food Chem.56, 5002–5007 (2008).
  • Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ338, b2337 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.